Also, the pharmacology from the Lively factors was largely uncharacterized, and affirmation of SCB use was hindered by an absence of recognised biomarkers. These knowledge gaps prompted experts throughout a number of disciplines to promptly (1) watch, establish and quantify with chromatography/mass spectrometry the at any time-altering contents of